February 14, 2018

FDA permits marketing of software to alert providers of potential strokes in patients

By: Judy Mathias
Share

Editor’s Note

The Food & Drug Administration (FDA) on February 13 announced that it is permitting the marketing of clinical decision support software that alerts providers to potential strokes in their patients.

The Viz.AI Contact application is designed to analyze computed tomography images of the brain and send a text notification to a neurovascular specialist if a suspected large vessel blockage is identified.

The algorithm will automatically notify the specialist during the same time the first-line provider is conducting a standard review of the images, involving the specialist sooner than the usual standard of care.

Read More >>

Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

Upcoming Webinars
Live chat by BoldChat